Detailed information for compound 536533

Basic information

Technical information
  • TDR Targets ID: 536533
  • Name: 6-(difluoromethoxy)-4-oxo-7-piperazin-1-yl-1H -quinoline-3-carboxylic acid
  • MW: 339.294 | Formula: C15H15F2N3O4
  • H donors: 3 H acceptors: 3 LogP: -0.05 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: FC(Oc1cc2c(cc1N1CCNCC1)[nH]cc(c2=O)C(=O)O)F
  • InChi: 1S/C15H15F2N3O4/c16-15(17)24-12-5-8-10(19-7-9(13(8)21)14(22)23)6-11(12)20-3-1-18-2-4-20/h5-7,15,18H,1-4H2,(H,19,21)(H,22,23)
  • InChiKey: BWUZDTRHFMTIKP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 6-(difluoromethoxy)-4-oxo-7-(1-piperazinyl)-1H-quinoline-3-carboxylic acid
  • 6-(difluoromethoxy)-4-keto-7-piperazino-1H-quinoline-3-carboxylic acid
  • 6-difluoromethoxy-7-piperazinyl-3-quinolonecarboxylic acid
  • 6-(difluoromethoxy)-4-keto-7-piperazin-1-yl-1H-quinoline-3-carboxylic acid
  • 121935-03-3
  • 3-Quinolinecarboxylic acid, 6-(difluoromethoxy)-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
  • DFMPQ

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus 0.0028 1 0.5
Echinococcus granulosus lamin dm0 0.0028 1 1
Loa Loa (eye worm) intermediate filament protein 0.0028 1 1
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.0019 0.4151 0.4151
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.0019 0.4151 0.5
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0019 0.4151 0.5
Loa Loa (eye worm) hypothetical protein 0.0027 0.9646 0.9646
Echinococcus multilocularis lamin 0.0028 1 1
Brugia malayi exodeoxyribonuclease III family protein 0.0019 0.4151 0.3482
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0019 0.4151 0.5
Treponema pallidum exodeoxyribonuclease (exoA) 0.0019 0.4151 0.5
Echinococcus multilocularis musashi 0.0028 1 1
Schistosoma mansoni lamin 0.0028 1 1
Loa Loa (eye worm) cytoplasmic intermediate filament protein 0.0015 0.1026 0.1026
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.0019 0.4151 0.4151
Trichomonas vaginalis ap endonuclease, putative 0.0019 0.4151 0.5
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.0019 0.4151 0.5
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.0019 0.4151 0.5
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0019 0.4151 0.5
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.0019 0.4151 0.4151
Toxoplasma gondii exonuclease III APE 0.0019 0.4151 0.5
Loa Loa (eye worm) intermediate filament tail domain-containing protein 0.0028 1 1
Loa Loa (eye worm) hypothetical protein 0.0028 1 1
Echinococcus granulosus intermediate filament protein 0.0028 1 1
Echinococcus multilocularis lamin dm0 0.0028 1 1
Entamoeba histolytica exodeoxyribonuclease III, putative 0.0019 0.4151 0.5
Echinococcus granulosus lamin 0.0028 1 1
Brugia malayi Intermediate filament tail domain containing protein 0.0028 1 1
Schistosoma mansoni lamin 0.0028 1 1
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.0019 0.4151 0.5
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0019 0.4151 0.5
Onchocerca volvulus 0.0028 1 0.5
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.0019 0.4151 0.5
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0019 0.4151 0.5
Schistosoma mansoni intermediate filament proteins 0.0028 1 1
Trichomonas vaginalis ap endonuclease, putative 0.0019 0.4151 0.5

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.